test

Marc Larkins

@Johnson & Johnson

Latest period2024 - Q3ReportedManaged Assets$427.326MTotal holdings20
Assets growth rate6.66%Assets growth rate (2-Q avg)-42.13%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Johnson & Johnson's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 20 positions.

Assets under management

The assets under management (AUM) of Johnson & Johnson over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 427.326M in assets, with a quarterly growth rate of 6.66% and a 2-quarter average growth rate of -42.13%. The portfolio is managed by Marc Larkins, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
FATEFate Therapeutics, Inc.
Recent Activity
2.77%
$11.827M
3.379M shares@ $3.5 avg price
ARWRArrowhead Pharmaceuticals, Inc.
Recent Activity
1.13%
$4.796M
247,598 shares@ $19.37 avg price
RLYBRallybio Corporation
Recent Activity
1%
$4.255M
3.636M shares@ $1.18 avg price
NNOXNano-x Imaging Ltd.
Recent Activity
0.23%
$965,820
158,852 shares@ $6.08 avg price
VORVor Biopharma, Inc.
Recent Activity
0.18%
$752,261
1.075M shares@ $0.71 avg price
LABStandard Biotools Inc
Recent Activity
0.15%
$602,096
311,967 shares@ $1.93 avg price
ACETAdicet Bio, Inc.
Recent Activity
0.13%
$524,840
364,472 shares@ $1.45 avg price
PHGEBiomx Inc.
Recent Activity
Decreased -89.99%
0.05%
$196,167
192,321 shares@ $1.02 avg price
CLSDClearside Biomedical, Inc.
Recent Activity
New Position
0.03%
$104,751
82,481 shares@ $1.28 avg price
SENSSenseonics Holdings, Inc.
Recent Activity
0.01%
$19,101
54,621 shares@ $0.35 avg price